Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology
|
December 23, 2016
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial
Joanne B Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma
Lazar Vujanovic, Pedro Torres-Saavedra, Fei Tu, et al.
Oral Oncology
|
July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer
Etienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
The Lancet. Oncology
|
January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J Sherman, Jonathan Harris, Keith C Bible, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
Jimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504
Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology
|
December 23, 2016
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial
Joanne B Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma
Lazar Vujanovic, Pedro Torres-Saavedra, Fei Tu, et al.
Oral Oncology
|
July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer
Etienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
The Lancet. Oncology
|
January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J Sherman, Jonathan Harris, Keith C Bible, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
Jimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504
Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Page
of 13